Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

Most of us could stand to eat more vegetables. Up your intake of this one vegetable and you can prevent cancer while also ...

Four out of 10 U.S. adults ages 18 to 44 have insulin resistance—and most don’t even know it. But what is insulin resistance, ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

In an effort to optimize weight goals, adults in the U.S. spend about $2.1 billion a year on weight loss supplements, according to the National Institutes of Health Office of Dietary Supplements. [1] ...

Given the controversial interplay between artificial sweeteners and weight loss, it’s not surprising that studies on their relationship abound. Unfortunately, the conclusions aren’t clear-cut.

Dr Wylie explains: ‘Weight loss of this magnitude is associated with a meaningful drop in the risk of type 2 diabetes, hypertension, sleep apnoea, and non-alcoholic fatty liver disease.

Among those who adhered to treatment, the high-dose group achieved an average weight loss of 20.7%, compared to 17.5% with the lower dose and 2.4% in the placebo group.

BBC Countryfile presenter Julia Bradbury underwent a full body MRI scan after her breast cancer diagnosis, and was shocked to ...